From the publishers of JADPRO

MPN Resource Center

Advertisement

Recent advances in the treatment of polycythemia vera

Last Updated: Friday, September 2, 2022

Updated results of clinical trials of pegylated interferon and ruxolitinib for the treatment of polycythemia vera, as well as emerging data on novel agents, are the spotlight for this review article.

Leukemia & Lymphoma
Advertisement
News & Literature Highlights
Advertisement
Advertisement